Lipid Metabolism Research Using MDA-MB-468 Cells
Lipid metabolism dysfunction is a hallmark of many diseases, particularly cancer, where altered fatty acid synthesis and lipid signaling pathways contribute to tumor progression and metastasis. The MDA-MB-468 cells, a triple-negative breast cancer cell line, have emerged as an invaluable research model for investigating lipid metabolism alterations in aggressive breast cancer subtypes. At Cytion, we provide high-quality MDA-MB-468 cells that enable researchers to explore the complex interplay between lipid metabolism and cancer biology, offering insights into potential therapeutic targets and biomarkers.
| Key Takeaways: MDA-MB-468 Cells in Lipid Metabolism Research | |
|---|---|
| Cell Line Origin | Triple-negative breast adenocarcinoma, highly aggressive phenotype |
| Metabolic Profile | Enhanced fatty acid synthesis, altered lipid signaling pathways |
| Research Applications | Lipid metabolism studies, drug screening, biomarker discovery |
| Key Advantages | Robust growth, consistent metabolic phenotype, drug-resistant characteristics |
| Culture Requirements | DMEM with 10% FBS, 37°C, 5% CO2 atmosphere |
| Quality Assurance | STR authenticated, mycoplasma-free, comprehensive CoA provided |
Cell Line Origin and Characteristics
The MDA-MB-468 cells originate from a pleural effusion of a 51-year-old Black female patient diagnosed with metastatic adenocarcinoma of the breast. This cell line represents one of the most aggressive forms of breast cancer, classified as triple-negative breast cancer (TNBC) due to its lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. The highly aggressive phenotype of MDA-MB-468 cells makes them particularly valuable for studying the metabolic reprogramming that occurs in advanced breast cancers. Unlike hormone-responsive MCF-7 cells, MDA-MB-468 cells exhibit enhanced invasive capabilities and altered lipid metabolism pathways that are characteristic of metastatic breast cancer. At Cytion, our MDA-MB-468 cells undergo rigorous cell line authentication to ensure genetic integrity and are supplied with comprehensive documentation for reliable research outcomes in lipid metabolism studies.
Enhanced Fatty Acid Synthesis and Lipid Signaling
The metabolic profile of MDA-MB-468 cells is characterized by dramatically upregulated fatty acid synthesis and dysregulated lipid signaling pathways that support their aggressive cancer phenotype. These cells exhibit overexpression of key lipogenic enzymes including fatty acid synthase (FASN), acetyl-CoA carboxylase (ACC), and ATP citrate lyase (ACLY), leading to increased de novo lipogenesis that fuels membrane biogenesis and energy production required for rapid proliferation and metastasis. The altered lipid metabolism in MDA-MB-468 cells also involves enhanced cholesterol biosynthesis and modified phospholipid composition, which affects membrane fluidity and cellular signaling. Unlike normal human cells, these cancer cells demonstrate increased lipid droplet formation and altered expression of lipid transport proteins, making them an ideal model for investigating how metabolic reprogramming supports cancer progression. Researchers utilizing our authenticated MDA-MB-468 cells can study these metabolic alterations using appropriate cell culture media formulations that maintain the cells' characteristic metabolic phenotype for consistent experimental results.
Research Applications in Lipid Metabolism Studies
The versatile research applications of MDA-MB-468 cells make them indispensable for comprehensive lipid metabolism studies, drug screening programs, and biomarker discovery initiatives. These cells serve as an excellent platform for investigating the efficacy of lipid metabolism inhibitors, including FASN inhibitors, statin-based cholesterol synthesis blockers, and novel compounds targeting lipid signaling pathways such as PI3K/AKT and mTOR. In drug screening applications, researchers can compare the metabolic responses of MDA-MB-468 cells with other breast cancer cell lines like MCF-7 cells to identify TNBC-specific therapeutic targets. For biomarker discovery, the distinct lipid profile of MDA-MB-468 cells enables identification of potential diagnostic markers and prognostic indicators related to fatty acid metabolism. Cytion's MDA-MB-468 cells undergo rigorous mycoplasma testing to ensure reliable results in these critical research applications, while our comprehensive technical support helps researchers optimize their experimental protocols for maximum reproducibility and scientific impact.
Key Advantages for Metabolic Research
The MDA-MB-468 cells offer several key advantages that make them superior for lipid metabolism research, including robust growth characteristics, consistent metabolic phenotype, and inherent drug-resistant properties that mirror clinical TNBC behavior. These cells demonstrate reliable proliferation rates and maintain stable passage-to-passage consistency, ensuring reproducible experimental outcomes across multiple research studies. The consistent metabolic phenotype of MDA-MB-468 cells is particularly valuable when studying long-term effects of metabolic interventions, as the cells retain their characteristic lipogenic enzyme expression and fatty acid synthesis patterns throughout extended culture periods. Their intrinsic drug-resistant characteristics make them ideal for screening potential therapeutics that can overcome the chemoresistance commonly observed in triple-negative breast cancers. At Cytion, we provide MDA-MB-468 cells that have been carefully maintained to preserve these advantageous properties, supported by our professional cell banking services and quality-controlled media and reagents that optimize cell performance while maintaining the metabolic characteristics essential for reliable lipid metabolism research.
Optimal Culture Requirements and Conditions
The successful cultivation of MDA-MB-468 cells requires specific culture conditions that maintain their characteristic metabolic profile and support robust growth for lipid metabolism research. These cells thrive in DMEM medium supplemented with 10% fetal bovine serum, which provides essential lipids and growth factors necessary for maintaining the cells' enhanced fatty acid synthesis pathways. The standard incubation conditions of 37°C in a humidified 5% CO2 atmosphere ensure optimal pH buffering and cellular metabolism, while regular medium changes every 2-3 days prevent nutrient depletion that could alter lipid metabolism patterns. For reliable experimental outcomes, it is crucial to use high-quality culture reagents and maintain consistent passage protocols, as variations in culture conditions can significantly impact the metabolic phenotype of these sensitive cancer cells. Cytion provides comprehensive culture protocols along with our MDA-MB-468 cells, and researchers can utilize our professional cell detachment reagents such as Accutase to ensure gentle passage procedures that preserve cell viability and metabolic integrity throughout extended culture periods.
Quality Assurance and Authentication Standards
At Cytion, we maintain the highest quality standards for our MDA-MB-468 cells through comprehensive quality assurance protocols that ensure reliability and reproducibility in lipid metabolism research. Each batch undergoes rigorous cell line authentication using Short Tandem Repeat (STR) profiling to confirm genetic identity and prevent cross-contamination with other cell lines, which is critical for maintaining the specific metabolic characteristics of this triple-negative breast cancer model. Our cells are guaranteed mycoplasma-free through extensive mycoplasma testing using both PCR and culture-based methods, ensuring that bacterial contamination does not interfere with cellular metabolism or experimental results. Every shipment includes a comprehensive Certificate of Analysis (CoA) documenting viability, sterility, authentication results, and culture performance data, providing researchers with complete traceability and quality documentation. Our commitment to quality extends beyond initial testing, as we offer additional services including premium mycoplasma testing and professional cell banking services to support long-term research projects and maintain consistent cell line quality throughout your studies.